Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
My Hep C Travel Diary, Hepatitis C Advocate
A story about taking one’s own health in to one’s own hands.
A story about hepatitis C and hope in Bosnia
Over the past few years I have written about how Pharma controls various advocacy groups and medical professionals via its funding programs.
The final phase of treatment is healing, repair and recovery. Its all about claiming our lives back and getting healthy again.
Some answers to questions about hepatitis C.
A close look at the price and profit of treatment.
A patient wonders if hep C treatment has also cleared his herpes virus.
Marie is one of around 2 million Nigerians infected with hepatitis C and all that I can do to help is to tell their story.
Africa has a population of about a billion people, likely with the highest hepatitis C infection levels in the world.
Want to know what I think the best treatment is for hepatitis C?
Every day, 7 days a week, I get an average 50 to 100 emails from people wanting information about hepatitis C.
For more than half of the world’s population the cost of standard pre-treatment HCV testing is beyond their ability to afford.
An email received after a recent post about cryoglobulinemia and hepatitis C reveals an interesting story.
A story of hope told in email exchanges.
Tips on diet during hepatitis C treatment while using sofosbuvir and daclatasvir
A discussion about affordable hepatitis C treatment.
What is the best hepatitis C treatment? Here are Greg’s insights.
Itching, scratching and rashes from hepatitis C. A look at some common skin problems associated with liver disease.
Greg Jefferys shares dismaying stories about hepatitis C treatment in Texas.
An in depth comparison of Mavyret versus Epclusa.
Some Tips For Taking Epclusa
Everyday I get emails from people around the world seeking information about generic hepatitis C medication...
Over the past five years Gilead has been averaging over $12 billion of profit per year from its sofosbuvir-based drugs.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.